From human immunodeficiency virus (HIV) infection of the brain to dementia

Genitourinary Medicine

Volumn 73, Issue 5, 1997, Pages 343-347

  Trillo Pazos, G ^a   Everall, I P ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

AIDS; Brain; Dementia; HIV

Indexed keywords

CYTOKINE; GLYCOPROTEIN GP 120; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

BRAIN INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NERVE CELL DIFFERENTIATION; NERVE CELL LESION; NEUROPATHOLOGY; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; VIRUS REPLICATION;

EID: 79959930130     PISSN: 02664348     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.73.5.343     Document Type: Review

References (41)

1. An SF, Ciardi A, Giometto B, Scaravilli T, Gray F, Scaravilli F. Investigation on the MHC class II and cytokines and detection of HIV-1 DNA within the brain of asymptomatic and symptomatic HIV-1 positive patients. Acta Neuropathol 1996;91:494-503.
2. Donaldson YK, Bell JE, Ironside JW, Brettle RP, Robertson JR, Busuttil, et al. Redistribution of HIV outside the lymphoid system with onset of AIDS, Lancet 1994;343:382-5.
3. Gray F, Scaravilli F, Everall I, Chretien F, An S, Boche D, et al. Neuropathology of early HIV-1 infection. Brain Pathol 1996;6:1-15.
4. Moses AV, Stenglein SG, Strussenberg JG, Wehrly K, Chesebro B, Nelson JA. Sequences regulating tropism of HIV-1 for brain capillary endothelial cells map to a unique region on the viral genome. J Virol 1996;70:3401-6.
5. Nottet H, Gendelman HE. Unraveling the neuroimmune mechanisms associated HIV-1 associated cognitive/ motor complex. Immunol Today 1995;16:441-8.
6. Hofman FM, Dohadwala MM, Wright AD, Hinton DR, Walker SM. Exogenous tat activates CNS derived endothelial cells. J Neuroimmunol 1994;54:19-28.
7. Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S. HIV-1 tat protein promotes chemotaxis and invasive behaviour by monocytes. J Immunol 1996; 157:974-7.
8. Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S. HIV-tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. J Immunol 1996;156:1638-45.
9. Nottet HSLM, Persidsky Y, Sasseville VG, Zhai Q-H, Bock P, Sharer LR, et al. Mechanisms of transendothelial migration of HIV-1 infected monocytes into the brain. J Immunol 1996;156:1284-95.
10. Schmidtmayerova H, Nottet HSL, Nuovo G, Raabe T, Flannagan CR, Dubrovsky L, et al. HIV-1 infection alters chemokine B peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci USA 1996;93:700-4.
11. Power C, McArthur JC, Johnson RT, Griffin DE, Glass JD, Dewey R, et al. Distinct HIV-1 env sequences are associated with neutropism and neurovirulence. Curr Top Microbiol Immunol 1995;202:89-101.
12. Budka H, Wiley CA, Kleihues P, Artigas J, Asbury AK, Cho ES, et al. HIV associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1991;1:143-52.
13. Everall IP, Lantos PL. The neuropathology of HIV: a review of the first 10 years. Int Rev Psych 1991;3:307-20.
14. McArthur JC. Neurologic diseases associated with HIV-1 infection. Curr Opin Infect Dis 1995;8:74-84.
15. Glass JD, Johnson RT. HIV and the brain. Annu Rev Neurosci 1996;19:1-26.
16. Everall IP, Gray F, Masliah E. Neuronal injury and apoptosis. In: Gendelman, Lipton, Epstein, Swindells, eds. Neurological and neuropsychiatrie manifestations of HIV-1 infection. New York: Chapman & Hall, 1997.
17. Everall IP, Luthert PJ, Lantos PL. Neuronal loss in the frontal cortex in HIV infection. Lancet 1991;337:1119-21.
18. Everall IP, Gray F, Barnes H, Durigon M, Luthert P, Lantos P. Neuronal loss in symptom-free HIV infection. Lancet 1992;340:1413.
19. Wiley CA, Masliah E, Morey M, Lemere, DeTeresa R, Grafe M, et al. Neocortical damage during HIV infection. Ann Neurol 1991;29:651-65.
20. Masliah E, Ge N, Morey M, De Teresa R, Terry RD, Wiley CA. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest 1992;66:285-91.
21. Masliah E, Ge N, Achim CL, DeTeresa R, Wiley CA. Patterns of neurodegeneration. euroAIDS 1996;1:161-73.
22. Bagasra O, Lavi E, Bobroski L, Khalili K, Pestaner JP, Tawadros R, et al. Cellular reservoirs of HIV-1 in the CNS of infected individuals:identification by the combination of in situ polymerase chain reaction and immuno-histochemistry. AIDS 1996;10:573-85.
23. Wiley CA, Baldwin M, Achim CL. Expression of HIV regulatory and structural mRNA an the CNS. AIDS 1996;10:843-7.
24. Trillo-Pazos G, Everall IP. Neuronal damage and its relation to dementia is acquired immunodeficiency syndrome (AIDS). Pathobiol 1996;64:245-307.
25. Ranki A, Lagerstedt A, Ovod V, Aavik E, Krohn KJ. Expression kinetics and subcellular localisation of HIV-1 regulatory proteins Nef, tat and Rev in acutely and chronically infected lymphoid cells. Arch Virol 1994; 139:365-78.
26. Kim YS, Panganiban AT. Examination of TAR-independent trans activation by HIV-1 tat in human glial cells. J Neurosci Res 1996;43:652-63.
27. Goldstein G. HIV-1 Tat as a potential AIDS vaccine. Nature Med 1996;1:960-4.
28. Attwood WJ, Berger Jr, Kaderman R, Tornatore CS, Major EO. Human immunodeficiency virus type 1 infection of the brain. Clin Microbiol Rev 1993;6:339-66.
29. Ramazotti E, Vignoli M, Re MC, Furlini G, La Placa M. Enhanced NF- B activation induced by TNF in stably tat-transfected cells is associated with the presence of cell surface bound tat protein. AIDS 1996;10:455-61.
30. Philippon V, Vellutini C, Gambarelli D, Harkiss G, Arbuthnott G, Metzger D, et al. The basic domain of the lentiviral Tat protein is responsible for damage in mouse brain involvement of cytokines. Virology 1994;205:519-29.
31. Lipton SA, Gendelman HE. Dementia associated with acquired immunodeficiency syndrome. N Engl J Med 1995;332:934-40.
32. Dawson TM, Dawson VL. Gp120 neurotoxicity in primary cortical cultures. Adv Neuroimmunol 1994;4:167-73.
33. Dawson VL, Dawson TM, Uhl GR, Snyder SH. HIV-1 coat protein neurotoxicity mediated by NO in primary cortical cultures. Proc Natl Acad Sci 1996;90:3256-9.
34. Giulian D, Wendt E, Vaca K, Noonan CA. The envelope glycoprotein of HIV-1 stimulates the release of neurotoxins from monocytes. Proc Nad Acad Sci 1993;90:2769-2.
35. Merril JE, Benveniste. Cytokines in inflammatory brain lesions: helpful and harmful. TINS 1996;19:331-8.
36. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system 1: actions and mechanisms of action. TINS 1995; 18:130-6.
37. Everall IP. Neuropsychiatric aspects of HIV infection. J Neurol Neurosur Psych 1995;58:399-401.
38. Di-Stefano M, Wilt S, Gray F, Dubois-Dalcq M, Chiodi F. HIV type 1 V3 sequences and the development of dementia during AIDS. AIDS Res Hum Retroviruses 1996;12:471-6.
39. Asare E, Dunn G, Glass J, McArthur J, Luthert P, Lantos P, et al. Neuronal pattern correlates with the severity of HIV associated dementia complex. Am J Pathol 1996;148:31-8.
40. Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, Farber JM, et al. Intracerebral cytokine mRNA expression in AIDS dementia. Ann Neurol 1993;33:576-82.
41. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996;274:1917-21.